NL-OMON34308招募中不适用
The effect of interleukin-1 receptor antagonist on insulin secretion in subjects with β-cell dysfunction. - Anakinra and insulin secretion
niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 16 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 16
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Impaired glucose tolerance assessed by oral glucose tolerance test and/or impaired fasting glucose ( >= 5.6 mmol/L) and/or HbA1c levels of 5.7-6.4%
- •- BMI >25 kg/m2
- •- Age 40-70 years
排除标准
- •- Known diabetes mellitus
- •- Fasting plasma glucose > 7.0 mmol/L or HbA1c > 6.5%
- •- Elevated risk for infections
- •- Pregnancy or breast-feeding
- •- Impaired liver and/or renal function
研究者
相似试验
进行中（未招募）
1 期
The effect of interleukin-1 receptor antagonist on insulin secretion - Anakinra and insulin secretioBeta-cell dysfunctionMedDRA version: 12.1Level: LLTClassification code 10052341Term: Impaired insulin secretionEUCTR2010-019660-36-NLMC St Radboud16
已完成
不适用
Effect of Interleukin-1 receptor antagonist on insulin sensitivity in obese, insulin resistant individualsmaturity-onset diabetestype 2 diabetes mellitus10018424NL-OMON33714niversitair Medisch Centrum Sint Radboud12
进行中（未招募）
1 期
Effect of Interleukin-1 receptor antagonist on insulin sensitivity in subjects with type 1 diabetes mellitus. - Effect of IL-1RA on insulin sensitivityMedDRA version: 12.1Level: LLTClassification code 10012601Term: Diabetes mellitusdiabetes mellitusEUCTR2010-023479-24-NLRadboud University Nijmegen Medical Centre16
已完成
2 期
Effect of Interleukin-1 receptor antagonist on insulin sensitivity in subjects with type 1 diabetes mellitus.10018424diabetesdiabetes mellitusNL-OMON34115niversitair Medisch Centrum Sint Radboud16
进行中（未招募）
不适用
Blocking the inflammation-factor IL-1 as treatment for degenerative joint disease of the handsosteoarthritis of the handEUCTR2012-004089-16-ATniversitätsklinik für Innere Medizin III, Klinische Abteilung für Rheumatologie, Medizinische Universität Wien